Hilla Solomon
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 21
- Cancer-related Molecular Pathways 18
- Cancer Cells and Metastasis 4
- Chemokine receptors and signaling 3
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Varda Rotter (27 shared papers)Naomi Goldfinger (17 shared papers)Shalom Madar (11 shared papers)Yosef Buganim (10 shared papers)Ran Brosh (8 shared papers)Ido Goldstein (9 shared papers)Ira Kogan-Sakin (7 shared papers)Alina Molchadsky (7 shared papers)
- Journals
- Cell Death and Differentiation (5 papers)Carcinogenesis (4 papers)PLoS ONE (3 papers)Cancer Research (2 papers)Journal of Cell Science (2 papers)
- Partner nations
- IsraelUnited StatesNorway
In The Last Decade
Hilla Solomon
31 papers receiving 2.0k citations
Hilla Solomon's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 534
- Oncology 930
- Biotechnology 162
- Molecular Biology 1.1k
- Immunology 242
Countries citing papers authored by Hilla Solomon
This map shows the geographic impact of Hilla Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilla Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilla Solomon more than expected).
Fields of papers citing papers by Hilla Solomon
This network shows the impact of papers produced by Hilla Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilla Solomon. The network helps show where Hilla Solomon may publish in the future.
Co-authors
The 25 scholars most cited alongside Hilla Solomon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer Hit paper breakdown → | 2013 | 413 |
| 2 | 2008 | 135 | |
| 3 | 2010 | 134 | |
| 4 | 2018 | 104 | |
| 5 | 2021 | 98 | |
| 6 | 2012 | 95 | |
| 7 | 2014 | 87 | |
| 8 | 2014 | 76 | |
| 9 | 2009 | 75 | |
| 10 | 2008 | 74 | |
| 11 | 2011 | 72 | |
| 12 | 2018 | 72 | |
| 13 | 2010 | 66 | |
| 14 | 2012 | 57 | |
| 15 | In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. | 1993 | 56 |
| 16 | 2010 | 54 | |
| 17 | 2011 | 53 | |
| 18 | 2017 | 45 | |
| 19 | 2011 | 39 | |
| 20 | Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. | 2010 | 36 |
About Hilla Solomon
Hilla Solomon is a scholar working on Oncology, Cancer Research, Molecular Biology, Biotechnology and Immunology, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), Cancer Research and Treatments (4 papers), RNA modifications and cancer (4 papers), Cancer Cells and Metastasis (4 papers), Cell death mechanisms and regulation (3 papers), Chemokine receptors and signaling (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (534 citations), Oncology (930 citations), Biotechnology (162 citations), Molecular Biology (1.1k citations) and Immunology (242 citations). Hilla Solomon has collaborated with scholars based in Israel, United States and Norway. Frequent co-authors include Varda Rotter, Naomi Goldfinger, Shalom Madar, Yosef Buganim, Ran Brosh, Ido Goldstein, Ira Kogan-Sakin, Alina Molchadsky, Curtis C. Harris and Moshe Oren. Their work appears in journals such as Cell Death and Differentiation, Carcinogenesis, PLoS ONE, Cancer Research and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.